Paik, E. S., Kim, T., Cho, Y. J., Ryu, J., Choi, J., Lee, Y., . . . Lee, J. (2020). Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer. Sci Rep.
Chicago-стиль цитированияPaik, E Sun, et al. "Preclinical Assessment of the VEGFR Inhibitor Axitinib As a Therapeutic Agent for Epithelial Ovarian Cancer." Sci Rep 2020.
MLA-цитированиеPaik, E Sun, et al. "Preclinical Assessment of the VEGFR Inhibitor Axitinib As a Therapeutic Agent for Epithelial Ovarian Cancer." Sci Rep 2020.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.